Lidocaine Cream Products Recalled for Improper Storage Conditions at Family Dollar
Family Dollar is recalling Aspercreme with Lidocaine Creme (SKU 999852) and Icy Hot Lidocaine Cream (SKU 999853) distributed April 30 through June 10, 2022 nationwide due to improper storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall addresses a CGMP manufacturing deviation regarding improper storage temperatures. The source provides no indication of reported illnesses or serious harm, supporting classification as a moderate manufacturing quality issue handled precautionarily.
Plain-English summary
Family Dollar Stores, LLC is recalling two topical lidocaine cream products: Aspercreme with Lidocaine Creme 1.75 oz (SKU 999852) and Icy Hot Lidocaine Cream 1.75 oz (SKU 999853). These products were distributed nationwide from April 30, 2022 through June 10, 2022.
The products are being recalled because they were held outside appropriate storage temperature conditions, which represents a deviation from Current Good Manufacturing Practice (CGMP) standards.
The recalled product
- Product
- ASPERCREME WITH LIDOCAINE CREME 1.75 OZ SKU 999852 ICY HOT LIDOCAINE CREAM 1.75 OZ SKU 999853 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical Cream
- Hazard
- improper-storage
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 999852
- 999853
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01